Curtin University
Clinical trials sponsored by Curtin University, explained in plain language.
-
New study aims to safely treat breastfeeding moms for malaria
Disease control Not yet recruitingThis study looks at how much of the malaria drugs primaquine and tafenoquine pass to babies through breast milk. It involves 60 breastfeeding mothers in Papua New Guinea who recently gave birth. The goal is to find a safe way to treat and prevent relapses of vivax malaria in new …
Phase: PHASE2, PHASE3 • Sponsor: Curtin University • Aim: Disease control
Last updated May 26, 2026 08:34 UTC
-
New hope for kids: shorter malaria cure tested in PNG
Disease control Not yet recruitingThis study tests the safety and effectiveness of tafenoquine, a single-dose medicine, for treating vivax malaria in 60 children in Papua New Guinea. Vivax malaria can hide in the liver and come back, so this treatment aims to clear both blood and liver parasites. The study will a…
Phase: PHASE4 • Sponsor: Curtin University • Aim: Disease control
Last updated May 22, 2026 13:54 UTC
-
Aspirin may slash liver cancer risk in cirrhosis patients, major trial launches
Prevention Not yet recruitingThis study tests whether taking a low-dose aspirin (100 mg) every day can prevent liver cancer in people with cirrhosis, a condition that raises cancer risk. About 890 adults from Australian hospitals will take aspirin or a placebo for 4 years while continuing their regular check…
Phase: PHASE3 • Sponsor: Curtin University • Aim: Prevention
Last updated May 22, 2026 13:50 UTC